You are here

Inlyta

ASCO: Merck KGaA, Pfizer's Bavencio combo misses survival mark in crowded kidney cancer space

Fierce Pharma

Thu, 05/23/24 - 09:52 pm

clinical tirals

Could Pfizer’s Inlyta have a role in Alzheimer’s disease?

Pharmaforum

Wed, 10/6/21 - 10:40 am

Alzheimer's disease

Merck and Pfizer’s Bavencio approved for renal cell carcinoma

Pharmaforum

Wed, 05/15/19 - 10:35 am

advanced renal cell carcinoma

Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer

Xconomy

Mon, 04/22/19 - 11:11 am

advanced renal cell carcinoma

Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster

Motley Fool

Tue, 02/19/19 - 12:20 pm

Merck, Pfizer drug combo extends kidney cancer survival -study

Yahoo/Reuters

Sun, 02/17/19 - 11:57 pm

Keytruda-Inlyta combo under Priority Review for first-line RCC

BioCentury

Fri, 02/15/19 - 10:34 am

renal cell carcinoma

priority review

Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer combination win

Fierce Pharma

Thu, 10/18/18 - 01:07 pm

Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer

Yahoo/Reuters

Tue, 09/11/18 - 09:28 am

Pfizer strikes out on Inlyta expansion bid with postsurgery kidney cancer failure

Fierce Pharma

Thu, 04/12/18 - 11:46 am

renal cell carcinoma

Pfizer Announces Failure of Phase 3 Trial of Axitinib as Adjuvant Treatment for Patients at High Risk of Renal Cell Carcinoma Recurrence After Surgery

CP Wire

Tue, 04/10/18 - 03:21 pm

renal cell carcinoma

Pfizer Announces Failure of Phase 3 Trial of Axitinib as Adjuvant Treatment for Patients at High Risk of Renal Cell Carcinoma Recurrence After Surgery

Tue, 04/10/18 - 02:44 pm

renal cell carcinoma

Pfizer Has Strong Track Record since 2010

Market Realist

Fri, 12/16/16 - 11:29 am

Pfizer’s Pipeline Story Begins to Unravel

Yahoo/YCharts

Fri, 08/30/13 - 12:32 pm

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Motley Fool

Mon, 05/6/13 - 09:12 am

ONYX Pharmaceuticals

Bristol-Myers Squibb

Pfizer cancer pill Inlyta gets EU approval for kidney cancer after failure of first treatment

Yahoo/AP

Tue, 09/4/12 - 12:24 pm

Pfizer says EU advisory panel recommends approval for its advanced kidney cancer drug Inlyta

Yahoo/AP

Fri, 05/25/12 - 11:15 am

FDA clears Pfizer drug for advanced kidney cancer

Yahoo/AP

Sat, 01/28/12 - 11:45 am

renal cell carcinoma